Format
Items per page
Sort by

Send to:

Choose Destination

Results: 8

1.

Net costs of hospital-acquired and pre-admission PUs among older people hospitalised in Ontario.

Chan B, Ieraci L, Mitsakakis N, Pham B, Krahn M.

J Wound Care. 2013 Jul;22(7):341-2, 344-6.

PMID:
24159655
2.

Twenty-four-hour ambulatory blood pressure monitoring in hypertension: an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2012;12(15):1-65. Epub 2012 May 1. Review. No abstract available.

3.

Internet-based device-assisted remote monitoring of cardiovascular implantable electronic devices: an evidence-based analysis.

Pron G, Ieraci L, Kaulback K; Medical Advisory Secretariat, Health Quality Ontario.

Ont Health Technol Assess Ser. 2012;12(1):1-86. Epub 2012 Jan 1. Review. No abstract available.

4.

Potentially preventable hospital use for dental conditions: implications for expanding dental coverage for low income populations.

QuiƱonez C, Ieraci L, Guttmann A.

J Health Care Poor Underserved. 2011 Aug;22(3):1048-58. doi: 10.1353/hpu.2011.0097.

PMID:
21841295
5.

Early prevention of pressure ulcers among elderly patients admitted through emergency departments: a cost-effectiveness analysis.

Pham B, Teague L, Mahoney J, Goodman L, Paulden M, Poss J, Li J, Ieraci L, Carcone S, Krahn M.

Ann Emerg Med. 2011 Nov;58(5):468-78.e3. doi: 10.1016/j.annemergmed.2011.04.033. Epub 2011 Aug 5.

PMID:
21820208
6.

Support surfaces for intraoperative prevention of pressure ulcers in patients undergoing surgery: a cost-effectiveness analysis.

Pham B, Teague L, Mahoney J, Goodman L, Paulden M, Poss J, Li J, Sikich NJ, Lourenco R, Ieraci L, Carcone S, Krahn M.

Surgery. 2011 Jul;150(1):122-32. doi: 10.1016/j.surg.2011.03.002. Review.

PMID:
21683861
7.

Collagen cross-linking using riboflavin and ultraviolet-a for corneal thinning disorders: an evidence-based analysis.

Pron G, Ieraci L, Kaulback K; Medical Advisory Secretariat, Health Quality Ontario.

Ont Health Technol Assess Ser. 2011;11(5):1-89. Epub 2011 Nov 1.

8.

Cost-effectiveness of biologic response modifiers compared to disease-modifying antirheumatic drugs for rheumatoid arthritis: a systematic review.

van der Velde G, Pham B, Machado M, Ieraci L, Witteman W, Bombardier C, Krahn M.

Arthritis Care Res (Hoboken). 2011 Jan;63(1):65-78. doi: 10.1002/acr.20338. Review. No abstract available.

PMID:
20740606
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk